Aptevo Therapeutics | ARS: Annual Report to Security Holders
Apr 23 16:20 ET
Aptevo Therapeutics | DEFA14A: Others
Apr 23 16:15 ET
Aptevo Therapeutics | DEF 14A: Definitive information statements
Apr 23 16:10 ET
Aptevo Therapeutics | 8-K: Current report
Apr 15 16:20 ET
Aptevo Therapeutics | 424B4: Prospectus
Apr 12 17:28 ET
Aptevo Therapeutics | EFFECT: Others
Apr 11 06:05 ET
Aptevo Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Apr 9 17:31 ET
Aptevo Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 29 17:04 ET
Aptevo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Mar 20 16:18 ET
Aptevo Therapeutics | 8-K: Current report
Mar 7 08:59 ET
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lamothe Jeffrey G.
Mar 5 17:18 ET
Aptevo Therapeutics | 8-K: Current report
Mar 5 17:12 ET
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Daphne
Mar 5 16:19 ET
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kwon SoYoung
Mar 5 16:13 ET
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White Marvin L
Mar 5 16:12 ET
Aptevo Therapeutics | 10-K: Annual report
Mar 5 08:32 ET
Aptevo Therapeutics | 8-K: Current report
Mar 5 08:17 ET
Aptevo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:28 ET
Aptevo Therapeutics | 8-K: Current report
Feb 6 16:38 ET
Aptevo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Daphne
Jan 30 18:08 ET
No Data
No Data